Abiopharma

🔍 Antturi Peter (Director)

Company: TEEKAY CORP LTD (TK)

Report Date: 2026-06-09

Detailed Transactions and Holdings:

• Acquired 6,350 shares of Deferred Restricted Stock Units (Derivative)
  Date: 2026-06-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 33,976.75 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each deferred RSU represents a vested right to receive one share of common stock of the issuer. The vested units may be released at the time the reporting person elects, no later than 10 years from the grant date.